Blood profile during and after hemoglobin substitute administration

International Journal of Artificial Organs

Volumn 23, Issue 2, 2000, Pages 119-124

  Mueller, Xavier M ^a   Tevaearai, H T ^a   Gardaz, J P ^a   Jegger, D ^a   Von Segesser, L K ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Biochemistry; Cardiopulmonary bypass; Hematology; Hemoglobin substitute

Indexed keywords

ANIMALS; BLOOD; DEPOSITS; HEMOGLOBIN; STARCH;

ANOVA TEST; BAXTER HEALTHCARES; BLOOD SAMPLES; CARDIOPULMONARY BYPASS; CROSSLINKED; HAEMATOLOGY; HAEMOGLOBINS; IN-VIVO; POST-OPERATIVE DAYS; REPEATED MEASUREMENTS;

BIOCHEMISTRY;

BLOOD SUBSTITUTE; DIASPIRIN CROSSLINKED HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; CARDIOPULMONARY BYPASS; COW; ERYTHROCYTE; HEMATOCRIT; HEMOPERFUSION; LEUKOCYTE; NONHUMAN; ORGAN PERFUSION; PLASMA OSMOLARITY; THROMBOCYTE;

EID: 0034025704     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880002300210     Document Type: Article

References (20)

1. Starnes JF Jr, Tewari A, Flokas K, Brown D, Van Kessel AL, Mondon CE. Effectiveness of a purified human hemoglobin as a blood substitute in the perfused rat liver. Gastroenterology 1991; 101: 1345-53.
2. Macdonald VW, Winslow RW. Oxygen delivery and myocardial function in rabbit hearts perfused with cell-free hemoglobin. J Appl Physiol 1992; 72, 476-83.
3. Hess JR, Wade CE, Winslow RM. Filtration-assisted exchange transfusion using Hb, and erythrocyte substitute. J Appl Physiol 1991; 70: 1639-44.
4. Przybelski RJ, Malcolm DS, Burris DG, Winslow RM. Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. J Lab Clin Med 1991; 117: 143-51.
5. Przybelski RJ, Kant GJ, Bounds MJ, Slayter MV, Winslow RM. Rate maze performance after resuscitation with cross-linked hemoglobin. J Lab Clin Med 1990; 115: 579-88.
6. Malcolm D, Kissinger D, Garrioch M. Diaspirin cross-linked hemoglobin solution as a resuscitative fluid following a severe hemorrhage in the rat. Biomat Artif Cell Artif Organs 1992; 20: 495-7.
7. Hindman BL, Dexter F, Cutkomp J, Smith T. Diaspirin cross-linked hemoglobin does not increase brain oxygen consumption during hypothermic cardiopulmonary bypass in rabbits. Anesthesiology 1995; 83: 1302-11.
8. von Segesser LK, Weiss BM, Hänseler E et al. Improved biocompatibility of heparin surface-coated ventricular assist devices, Int J Artif Organs 1992; 15: 301-6.
9. Snyder SR, Welty EV, Walder RY, Williams LA, Walder JA. HbXI99α: A hemoglobin derivative that is cross-linked between the α subunits is useful as a blood substitute. Proc Natl Acad Sci USA 1987; 84: 7280-4.
10. Chatterjee R, Welty EV, Walder RY, et al. Isolation and characterization of a new hemoglobin derivative cross-linked between the αchains (Lysine 99α1-Lysine 99α2). J Biol Chem 1986; 261: 9929-37.
11. Hess JR, Fadare SO, Tolentina LSL, Bangal NR, Winslow RM. The intravascular persistence of cross-linked human hemoglobin. In: Brewer G, ed. Progress in clinical and biological research (vol 319). Red Cell: 7th Ann Arbor Conference. Edited by Brewer G, New York: Alan R Liss, 1989; 351-60.
12. Peterson KA, Dewanjee MK, Kaye MP. Fate of indium 111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators. J Thorac Cardiovasc Surg 1982; 84: 39-43.
13. van Oeveren W, Kazatchkine MD, Descamps-Latscha B, Maillet F, Fischer E, Carpentier A. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg 1985; 89: 888-99.
14. Hammerschmidt DE, Stroncek DF, Bowers TK, et al. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 81: 370-7.
15. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497-503.
16. Fischer SR, Burnet M, Traber DL, Prough DS, Kramer GC. Plasma volume expansion with solutions of hemoglobin, albumin, and Ringer lactate in sheep. Am J Physiol 1999; 276: H2194-2203.
17. De Angeles DA, Scott AM, McGrath AM, et al. Resuscitation from hemorrhagic shock with diaspirin cross-linked hemoglobin, blood, or hetasarch. J Trauma 1997; 42: 412-14.
18. Rea G, Bodenham AR, Mallik A, Daily EK, Przybelski RJ. Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Critical Care Medicine 1997; 25: 1480-8.
19. Baron JF, Berridge J, Brichant JF, on behalf of the DCLHb Cardiac Surgery Trial Collaborative Group. A randomized trial to assess the efficacy of diaspirin crosslinked hemoglobin (DCLHb) solution as an alternative to blood transfusion following cardiac surgery. Anesthesiology 1997; 87: A217.
20. Swan SK, Halstenson CE, Collins AJ, Colburn WA, Blue J, Przybelski RJ. Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients. Am J Kidney Dis 1995; 26: 918-23.